Viral Vitalism

Source Library

Newswise: CAR-T cell therapy leads to 10-year remissions in B-cell lymphoma patients

Syndicated institutional coverage for Penn 10-year CAR-T follow-up.

ArticleGeneral published source
Source type
Article
Access type
Publisher
Publisher
Newswise
Date
2026-06-24
Added
2026-07-05
Open original ->Source index

Trust profile

VV Source Trust Matrix v1.0

VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.

60

General published source

Publisher type
General media
Bias profile
Elevated

This source is strongest for consumer context and regulatory status and weaker for safety and trial discovery.

VV Source Fit Score 1.0

Fit by use case

Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.

Frameworks ->
Regulatory status
54/100
Weak Support
Clinical outcomes
54/100
Weak Support
Mechanism
54/100
Weak Support
Safety
54/100
Weak Support
Consumer context
67/100
Context Source
Trial discovery
54/100
Weak Support

Best used for

  • Context
  • Public narrative

Weak for

  • Clinical claims
  • Safety conclusions
  • Regulatory status

Used in Viral Vitalism

Related studies

No structured study record is currently attached to this source.

Related sources

Topic tags

car-tcell-therapylymphomablood-cancerpenn-medicinelong-term-remission

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No selling your information. Unsubscribe anytime.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.